Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-259895 |
|
|
Homo sapiens |
Ovary Cancer Cell |
pmid |
sentence |
26351349 |
Nivolumab is an anti-PD-1 antibody that blocks PD-1 signaling. We assessed the safety and antitumor activity of nivolumab in patients with platinum-resistant ovarian cancer. |
|